235 related articles for article (PubMed ID: 36456989)
21. Women With Ovarian Cancer and With Fertility Preservation: A Survival Analysis Using the Surveillance, Epidemiology, and End Results Database and Construction of Nomograms to Predict Cancer-Specific Survival.
Hou YM; Yu H; Hao JT; Feng F; An RF
Front Oncol; 2022; 12():860046. PubMed ID: 35480098
[TBL] [Abstract][Full Text] [Related]
22. Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis.
Manning-Geist BL; Chi DS; Long Roche K; Zivanovic O; Sonoda Y; Gardner GJ; O'Cearbhaill RE; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2021 Aug; 162(2):345-352. PubMed ID: 34045053
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.
Yuan D; Zhu H; Wang T; Zhang Y; Zheng X; Qu Y
Eur J Med Res; 2023 Oct; 28(1):465. PubMed ID: 37884970
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
Li S; Zhu Z
J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
[TBL] [Abstract][Full Text] [Related]
25. The Prevalence and associated Factors for Liver Metastases, Development and Prognosis in newly diagnosed Epithelial Ovarian Cancer: A large Population-Based Study from the SEER Database.
Hussain I; Xu J; Deng K; Noor-Ul-Amin ; Wang C; Huang Y; Li S; Li K
J Cancer; 2020; 11(16):4861-4869. PubMed ID: 32626533
[No Abstract] [Full Text] [Related]
26. Prognosis prediction and comparison between pancreatic signet ring cell carcinoma and pancreatic duct adenocarcinoma: a retrospective observational study.
Zhou H; Li XX; Huang YP; Wang YX; Zou H; Xiong L; Liu ZT; Wen Y; Zhang ZJ
Front Endocrinol (Lausanne); 2023; 14():1205594. PubMed ID: 37534212
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy.
Lin J; Xu X; Sun D; Li T
Front Oncol; 2020; 10():626555. PubMed ID: 33680950
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinoma.
Kilic F; Ersak B; Cakir C; Yuksel D; Kilic C; Korkmaz V; Tokgozoglu N; Toptas T; Boran N; Kimyon Comert G; Ureyen I; Tasci T; Moraloglu Tekin O; Ustun Y; Turan T
J Obstet Gynaecol Res; 2024 Jan; 50(1):86-94. PubMed ID: 37854000
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
[TBL] [Abstract][Full Text] [Related]
30. Clinical factors associated with prognosis in low-grade serous ovarian carcinoma: experiences at two large academic institutions in Korea and Taiwan.
Kang JH; Lai YL; Cheng WF; Kim HS; Kuo KT; Chen YL; Lee YY
Sci Rep; 2020 Nov; 10(1):20012. PubMed ID: 33203969
[TBL] [Abstract][Full Text] [Related]
31. The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.
van Baal JOAM; Van de Vijver KK; Algera MD; van der Aa MA; Sonke GS; van Driel WJ; Kenter GG; Amant FC; Lok CAR
Gynecol Oncol; 2019 Jun; 153(3):562-567. PubMed ID: 30948193
[TBL] [Abstract][Full Text] [Related]
32. Do ethnic chinese older adults with epithelial ovarian cancer survive a poorer prognosis?
Huang W; Bao Y; Luo X; Yao L; Yuan L
J Ovarian Res; 2023 Jun; 16(1):110. PubMed ID: 37277766
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological parameters and survival of invasive epithelial ovarian cancer by histotype and disease stage.
Lan A; Yang G
Future Oncol; 2019 Jun; 15(17):2029-2039. PubMed ID: 31140868
[No Abstract] [Full Text] [Related]
35. Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database.
Li X; Yang Q; Chen M; Yang C; Gu J; Dong Q; Yang G
J Ovarian Res; 2021 Feb; 14(1):40. PubMed ID: 33640000
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic staging for apparent stage I epithelial ovarian cancer.
Melamed A; Keating NL; Clemmer JT; Bregar AJ; Wright JD; Boruta DM; Schorge JO; Del Carmen MG; Rauh-Hain JA
Am J Obstet Gynecol; 2017 Jan; 216(1):50.e1-50.e12. PubMed ID: 27567562
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
[TBL] [Abstract][Full Text] [Related]
38. HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Miller KR; Patel JN; Zhang Q; Norris EJ; Symanowski J; Michener C; Sehouli J; Braicu I; Destephanis DD; Sutker AP; Jones W; Livasy CA; Biscotti C; Ganapathi RN; Tait DL; Ganapathi MK
Gynecol Oncol; 2018 Apr; 149(1):155-162. PubMed ID: 29402501
[TBL] [Abstract][Full Text] [Related]
39. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and prognostic factors of stage IC ovarian clear cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Chen Q; Wang S; Lang JH
Arch Gynecol Obstet; 2021 Aug; 304(2):521-529. PubMed ID: 33543331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
